Home / 2012 / November (page 12)

Monthly Archives: November 2012

Starting Basal and Bolus Insulins, Part 2

DCMS109HS

  In this week’s set of Homerun Slides, we continue with our exploration of new insulins with a brief overview of the different treatments for type 1 and type 2 diabetes as well as a comparison of human insulins and insulin analogues, and their timing and effectiveness. (This also ties …

Read More »

Letter from the Editor #650

Last week CMS finally issued guidelines temporarily increasing primary-care physician payments from Medicaid. The new Medicaid Rule (click here for the complete PDF) which implements a provision of the Patient Protection and Affordable Care Act, details the extent and target of the increase, which takes effect in January and lasts through …

Read More »

Vitafusion® Fiber Well® – Weight Management Gummies

  Vitafusion® Fiber Well® – Weight Management Gummies  As an aid to weight loss, fiber can help patients maintain satiety longer so they eat less of other foods. There are 5 grams of soluble fiber in 2 pieces. Soluble fiber has also been associated with lowering LDL levels and decreasing …

Read More »

Levemir® Label Update

Levemir® Label Update Levemir® (insulin detemir [rDNA origin] injection) has been approved for use in combination with metformin and a GLP-1 receptor agonist. In the study, when Levemir® once daily added on to metformin + Victoza, 50% of patients reached A1c goal

Read More »

New Insulin Analog Shows Promise

The novel basal insulin analog LY2605541 may show advantages over insulin glargine in diabetes patients, according to researchers. Dr. Melvin J. Prince, Eli Lilly and Company, stated, "These Phase II results in basal insulin-treated patients with type 2 diabetes showed that LY2605541 improved glycemic control comparable to that seen with …

Read More »

Diabetes Drug Possible Treatment for Cocaine Addiction

A drug used for the medical management of type 2 diabetes could be just as effective in treating drug addiction, including cocaine, researchers have revealed. Gregg Stanwood, PhD, assistant professor of Pharmacology and an investigator within the Vanderbilt Kennedy Center and Vanderbilt Brain Institute, stated, "What we have demonstrated is that a brain …

Read More »